Alternative Splicing-Based Differences Between Hepatocellular Carcinoma and Intrahepatic Cholangiocarcinoma: Genes, Immune Microenvironment, and Survival Prognosis

Alternative splicing (AS) event is a novel biomarker of tumor tumorigenesis and progression. However, the comprehensive analysis of hepatocellular carcinoma (HCC) and intrahepatic cholangiocarcinoma (ICC) is lacking. Differentially expressed analysis was used to identify the differentially expressed...

Descripción completa

Detalles Bibliográficos
Autores principales: Luo, Dingan, Zhao, Deze, Zhang, Mao, Hu, Chuan, Li, Haoran, Zhang, Shun, Chen, Xiaowu, Huttad, Lakshmi, Li, Bailiang, Jin, Cheng, Lin, Changwei, Han, Bing
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574058/
https://www.ncbi.nlm.nih.gov/pubmed/34760694
http://dx.doi.org/10.3389/fonc.2021.731993

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8574058/
https://www.ncbi.nlm.nih.gov/pubmed/34760694
http://dx.doi.org/10.3389/fonc.2021.731993

Ejemplares similares